High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice

Neurobiology of Disease

Volumn 69, Issue , 2014, Pages 248-262

  Mo, Christina ^a   Pang, Terence Y ^a   Ransome, Mark I ^a   Hill, Rachel A ^a   Renoir, Thibault ^a   Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cell proliferation; Corticosterone treatment; HPA axis; Huntington's disease; Short term memory; Stress hormone; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; STRESS HORMONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUID INTAKE; HIPPOCAMPUS; HORMONE BLOOD LEVEL; HUNTINGTON CHOREA; MALE; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ROTAROD TEST; SEX DIFFERENCE; SHORT TERM MEMORY; STRESS; Y-MAZE TEST; ANIMAL; DISEASE MODEL; MAZE TEST; METABOLISM; MOTOR ACTIVITY; ONSET AGE; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL DEVELOPMENT; TRANSGENIC MOUSE;

AGE OF ONSET; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL PROLIFERATION; CORTICOSTERONE; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUNTINGTON DISEASE; MALE; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE, TRANSGENIC; MOTOR ACTIVITY; RECEPTOR, TRKB; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RNA, MESSENGER; ROTAROD PERFORMANCE TEST; SEX CHARACTERISTICS;

EID: 84903629783     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.05.004     Document Type: Article

References (102)

1. Abbott L.F., Nelson S.B. Synaptic plasticity: taming the beast. Nat. Neurosci. 2000, 3:1178-1183.
2. Adlard P.A., et al. The exercise-induced expression of BDNF within the hippocampus varies across life-span. Neurobiol. Aging 2005, 26:511-520.
3. Aziz N.A., et al. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J. Clin. Endocrinol. Metab. 2009, 94:1223-1228.
4. Barnabé-Heider F., Miller F.D. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J. Neurosci. 2003, 23:5149-5160.
5. Birt D.F., et al. Corticosterone supplementation reduced selective protein kinase C isoform expression in the epidermis of adrenalectomized mice. Cancer Epidemiol. Biomark. Prev. 2001, 10:679-685.
6. Bjorkqvist M., et al. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 2006, 15:1713-1721.
7. Bombard Y., et al. Beyond the patient: the broader impact of genetic discrimination among individuals at risk of Huntington disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2012, 159B:217-226.
8. Brito V., et al. Imbalance of p75NTR/TrkB protein expression in Huntington/'s disease: implication for neuroprotective therapies. Cell Death Dis. 2013, 4:e595.
9. Brummelte S., Galea L.A.M. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience 2010, 168:680-690.
10. Buruma O.J.S., et al. Which factors influence age at onset and rate of progression in Huntington's disease?. J. Neurol. Sci. 1987, 80:299-306.
11. Bussiere J., et al. Androgen deprivation impairs memory in older men. Behav. Neurosci. 2005, 119:1429-1437.
12. Choi S.H., Li Y., Parada L.F., Sisodia S.S. Regulation of hippocampal progenitor cell survival, proliferation and dendritic development by BDNF. Molecular Neurodegeneration 2009, 4:52. 10.1186/1750-1326-4-52.
13. Clifford J.J., et al. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease. Neuroscience 2002, 109:81-88.
14. Conrad C.D., et al. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav. Neurosci. 1996, 110:1321-1334.
15. Conrad C.D., et al. Acute stress impairs spatial memory in male but not female rats: influence of estrous cycle. Pharmacol. Biochem. Behav. 2004, 78:569-579.
16. Donner N.C., et al. Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression. Psychoneuroendocrinology 2012, 37:645-661.
17. Downing N., et al. Perceived stress in prodromal Huntington disease. Psychol. Health 2012, 27:196-209.
18. Du X., et al. Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease. Transl. Psychiatry 2012, 2:e133.
19. Duan W., et al. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100.
20. Espósito M.S., et al. Neuronal differentiation in the adult hippocampus recapitulates embryonic development. J. Neurosci. 2005, 25:10074-10086.
21. Etkin A., et al. A role in learning for SRF: deletion in the adult forebrain disrupts LTD and the formation of an immediate memory of a novel context. Neuron 2006, 50:127-143.
22. Gharami K., et al. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J. Neurochem. 2008, 105:369-379.
23. Giralt A., et al. Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseC[gamma] activity and glutamate receptor expression. Neuroscience 2009, 158:1234-1250.
24. Gourley S.L., et al. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol. Psychiatry 2008, 64:884-890.
25. Gourley S.L., et al. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol. Psychiatry 2008, 63:353-359.
26. Gourley S.L., et al. Corticosteroid-induced neural remodeling predicts behavioral vulnerability and resilience. J. Neurosci. 2013, 33:3107-3112.
27. Hannan A.J., Ransome M.I. Deficits in spermatogenesis but not neurogenesis are alleviated by chronic testosterone therapy in R6/1 Huntington's disease mice. J. Neuroendocrinol. 2012, 24:341-356.
28. Harrison F.E., et al. Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks. Behav. Brain Res. 2009, 198:247-251.
29. Harrison D.J., et al. Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model. Exp. Neurol. 2013, 248:457-469.
30. Hermel E., et al. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ. 2004, 11:424-438.
31. Hill R.A., et al. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5HT2C receptor knockout mice. Hippocampus 2011, 21:434-445.
32. Hillerer K.M., et al. Sex-dependent regulation of hippocampal neurogenesis under basal and chronic stress conditions in rats. Hippocampus 2013, 23:476-487.
33. Ho A.K., et al. Health-related quality of life in Huntington's disease: which factors matter most?. Mov. Disord. 2009, 24:574-578.
34. Hockly E., et al. Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann. Neurol. 2002, 51:235-242.
35. Hodes G.E., et al. Strain differences in the effects of chronic corticosterone exposure in the hippocampus. Neuroscience 2012, 222:269-280.
36. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
37. Jacobsen J.P.R., Mørk A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 2006, 1110:221-225.
38. Janowsky J.S., et al. Sex steroids modify working memory. J. Cogn. Neurosci. 2000, 12:407-414.
39. Jeanneteau F., Chao M.V. Are BDNF and glucocorticoid activities calibrated?. Neuroscience 2013, 239:173-195.
40. Jeanneteau F., et al. Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect. Proc. Natl. Acad. Sci. 2008, 105:4862-4867.
41. Karatsoreos I.N., et al. Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 2010, 151:2117-2127.
42. Khalil H., et al. What effect does a structured home-based exercise programme have on people with Huntington's disease? A randomized, controlled pilot study. Clin. Rehabil. 2013, 27:646-658.
43. Kutiyanawalla A., et al. Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PLoS One 2011, 6:e26153.
44. Lazic S.E., et al. Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment. Eur. J. Neurosci. 2006, 23:1829-1838.
45. Li Y., Luikart B.W., Birnbaum S., Chen J., Kwon C.-H., et al. TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive Treatment. Neuron 2008, 59:399-412. 10.1016/j.neuron.2008.06.023.
46. Li M., et al. Infusion of BDNF into the nucleus accumbens of aged rats improves cognition and structural synaptic plasticity through PI3K-ILK-Akt signaling. Behav. Brain Res. 2012, 231:146-153.
47. López-Sendón J.L., et al. What is the impact of education on Huntington's disease?. Mov. Disord. 2011, 26:1489-1495.
48. Luine V., Frankfurt M. Interactions between estradiol, BDNF and dendritic spines in promoting memory. Neuroscience 2013, 239:34-45.
49. Magariños A.M.A., et al. Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: a paradox. Brain Res. 1998, 809:314-318.
50. Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003, 28:1562-1571.
51. Mangiarini L., et al. Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
52. Marder K., et al. Dietary intake in adults at risk for Huntington disease: analysis of PHAROS Research Participants. Neurology 2009, 73:385-392.
53. Marder K., et al. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease. JAMA Neurol. 2013, 70:1382-1388.
54. Markianos M., et al. Plasma testosterone in male patients with Huntington's disease: Relations to severity of illness and dementia. Ann. Neurol. 2005, 57:520-525.
55. McEwen B.S., et al. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 2012, 62:3-12.
56. Meudell P., et al. The role of rehearsal in the short-term memory performance of patients with Korsakoff's and Huntington's disease. Neuropsychologia 1978, 16:507-510.
57. Mizoguchi K., et al. Chronic stress impairs rotarod performance in rats: implications for depressive state. Pharmacol. Biochem. Behav. 2002, 71:79-84.
58. Mizuno M., et al. Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation. Mol. Psychiatry 2003, 8:217-224.
59. Mo C., et al. Short-term memory acquisition in female Huntington's disease mice is vulnerable to acute stress. Behav. Brain Res. 2013, 253:318-322.
60. Murray F., et al. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur. J. Pharmacol. 2008, 583:115-127.
61. Myers R.H. Huntington's disease genetics. NeuroRx 2004, 1:255-262.
62. Nithianantharajah J., et al. Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol. Dis. 2008, 29:490-504.
63. Pang T.Y.C., et al. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 2006, 141:569-584.
64. Pang T.Y.C., et al. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 2009, 18:753-766.
65. Patapoutian A., Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 2001, 11:272-280.
66. Paulsen J.S., et al. Depression and stages of Huntington's disease. J. Neuropsychiatry Clin. Neurosci. 2005, 17:496-502.
67. Peltier J., et al. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev. Neurobiol. 2007, 67:1348-1361.
68. Peng Q., et al. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp. Neurol. 2008, 210:154-163.
69. Ransome M.I., Hannan A.J. Impaired basal and running-induced hippocampal neurogenesis coincides with reduced Akt signaling in adult R6/1 HD mice. Mol. Cell. Neurosci. 2013, 54:93-107.
70. Ransome M.I., Turnley A.M. Growth hormone signaling and hippocampal neurogenesis: insights from genetic models. Hippocampus 2008, 18:1034-1050.
71. Renoir T., et al. Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise. Br. J. Pharmacol. 2012, 165:1375-1389.
72. Reul J.M.H.M., De Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
73. Roskoden T., et al. Early postnatal corticosterone administration regulates neurotrophins and their receptors in septum and hippocampus of the rat. Exp. Brain Res. 2004, 154:183-191.
74. Sapolsky R.M., et al. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 1984, 114:287-292.
75. Schaaf M.J.M., et al. Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus. J. Neurosci. Res. 1997, 48:334-341.
76. Schaaf M.J., et al. Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress (Amsterdam, Netherlands) 2000, 3:201-208.
77. Schoenfeld M., et al. Increased rate of suicide among patients with Huntington's disease. J. Neurol. Neurosurg. Psychiatry 1984, 47:1283-1287.
78. Scholz O., Berlemann C. Memory performance in Huntington's disease. Int. J. Neurosci. 1987, 35:155-162.
79. Simonin C., et al. Association between caffeine intake and age at onset in Huntington's disease. Neurobiol. Dis. 2013, 58:179-182.
80. Spencer-Segal J.L., et al. Distribution of phosphorylated trkB receptor in the mouse hippocampal formation depends on sex and estrous cycle stage. J. Neurosci. 2011, 31:6780-6790.
81. Spencer-Segal J.L., et al. Estradiol acts via estrogen receptors alpha and beta on pathways important for synaptic plasticity in the mouse hippocampal formation. Neuroscience 2012, 202:131-146.
82. Spires T.L., et al. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J. Neurosci. 2004, 24:2270-2276.
83. Stone E.A., Lin Y. An anti-immobility effect of exogenous corticosterone in mice. Eur. J. Pharmacol. 2008, 580:135-142.
84. Suri D., Vaidya V.A. Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity. Neuroscience 2013, 239:196-213.
85. Tornello S., et al. Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats. Neuroendocrinology 1982, 35:411-417.
86. Trembath K., et al. A retrospective study of the impact of lifestyle on age at onset of Huntington disease. Mov. Disord. 2010, 58:179-182.
87. Tropea D., et al. Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience. Eur. J. Neurosci. 2001, 13:709-721.
88. van Dellen A., et al. Delaying the onset of Huntington's in mice. Nature 2000, 404:721-722.
89. van Dellen A., et al. Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease. BMC Neurosci. 2008, 9:34.
90. Van Raamsdonk J.M., et al. Testicular degeneration in Huntington disease. Neurobiol. Dis. 2007, 26:512-520.
91. Vellucci S.V., et al. Chronic dexamethasone-treatment alters mineralocorticoid receptor, truncated trkB and selected glutamate receptor subunit mRNA expression in the porcine hippocampus. Neuropeptides 2002, 36:291-298.
92. Vogel C., Marcotte E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 2012, 13:227-232.
93. Wexler N.S., et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3498-3503.
94. Wong E.Y.H., Herbert J. Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus. Eur. J. Neurosci. 2005, 22:785-792.
95. Wood N.I., et al. "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease. Neurobiol. Dis. 2011, 42:427-437.
96. Wu T.-C., et al. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology 2013, 38:871-883.
97. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/trkB signaling in memory processes. J. Pharmacol. Sci. 2003, 91:267-270.
98. Yi L.-T., et al. Ethanol extracts from Hemerocallis citrina attenuate the decreases of brain-derived neurotrophic factor, trkB levels in rat induced by corticosterone administration. J. Ethnopharmacol. 2012, 144:328-334.
99. Young E.A., et al. Negative feedback regulation following administration of chronic exogenous corticosterone. J. Neuroendocrinol. 1995, 7:37-45.
100. Zajac M.S., et al. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice. Hippocampus 2009, 20:621-636.
101. Zuccato C., Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 2007, 81:294-330.
102. Zuccato C., et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 2001, 293:493-498.